Search

Search bills, members, committees and pages...

UPSTREAM CONSULTING

76 federal lobbying filings, 2023 to 2026.

UPSTREAM CONSULTING is a registrant on 76 federal lobbying filings, 2023 to 2026, reporting $1.4M across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Clients

7 who it filed for, by filings.

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
202610$185K
202520$340K
202420$340K
202326$565K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues30
CSPConsumer Issues/Safety/Products14
MMMMedicare/Medicaid14
LAWLaw Enforcement/Crime/Criminal Justice9
LBRLabor Issues/Antitrust/Workplace9
GOVGovernment Issues5
FOOFood Industry (safety, labeling, etc.)2

Lobbyists

Named on the filings.

LobbyistClientsFilings
MCCLAIN HADDOW774

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
ZIONS THERAPEUTICSUPSTREAM CONSULTING2026 second_quarter$15KJul 18, 2026
RARE ACCESS ACTION PROJECTUPSTREAM CONSULTING2026 second_quarter$15KJul 18, 2026
PRIMUS PHARMACEUTICALUPSTREAM CONSULTING2026 second_quarterJul 18, 2026
AMERICAN KRATOM ASSOCIATIONUPSTREAM CONSULTING2026 second_quarter$47.5KJul 18, 2026
MANAGEMENT & TRAINING CORPORATIONUPSTREAM CONSULTING2026 second_quarter$22.5KJul 18, 2026
ZIONS THERAPEUTICSUPSTREAM CONSULTING2026 first_quarterMay 4, 2026
RARE ACCESS ACTION PROJECTUPSTREAM CONSULTING2026 first_quarter$15KMay 4, 2026
PRIMUS PHARMACEUTICALUPSTREAM CONSULTING2026 first_quarterMay 4, 2026
AMERICAN KRATOM ASSOCIATIONUPSTREAM CONSULTING2026 first_quarter$47.5KMay 4, 2026
MANAGEMENT & TRAINING CORPORATIONUPSTREAM CONSULTING2026 first_quarter$22.5KMay 4, 2026
ZIONS THERAPEUTICSUPSTREAM CONSULTING2025 fourth_quarterJan 30, 2026
RARE ACCESS ACTION PROJECTUPSTREAM CONSULTING2025 fourth_quarter$15KJan 30, 2026
PRIMUS PHARMACEUTICALUPSTREAM CONSULTING2025 fourth_quarterJan 30, 2026
AMERICAN KRATOM ASSOCIATIONUPSTREAM CONSULTING2025 fourth_quarter$47.5KJan 30, 2026
MANAGEMENT & TRAINING CORPORATIONUPSTREAM CONSULTING2025 fourth_quarter$22.5KJan 30, 2026
ZIONS THERAPEUTICSUPSTREAM CONSULTING2025 third_quarterOct 25, 2025
RARE ACCESS ACTION PROJECTUPSTREAM CONSULTING2025 third_quarter$15KOct 25, 2025
PRIMUS PHARMACEUTICALUPSTREAM CONSULTING2025 third_quarterOct 25, 2025
AMERICAN KRATOM ASSOCIATIONUPSTREAM CONSULTING2025 third_quarter$47.5KOct 25, 2025
MANAGEMENT & TRAINING CORPORATIONUPSTREAM CONSULTING2025 third_quarter$22.5KOct 25, 2025
ZIONS THERAPEUTICSUPSTREAM CONSULTING2025 second_quarterAug 1, 2025
RARE ACCESS ACTION PROJECTUPSTREAM CONSULTING2025 second_quarter$15KAug 1, 2025
PRIMUS PHARMACEUTICALUPSTREAM CONSULTING2025 second_quarterAug 1, 2025
AMERICAN KRATOM ASSOCIATIONUPSTREAM CONSULTING2025 second_quarter$47.5KAug 1, 2025
MANAGEMENT & TRAINING CORPORATIONUPSTREAM CONSULTING2025 second_quarter$22.5KAug 1, 2025